Evid Invest
Holders — by stockHoldings — by fund

Prosight Management, LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001617201

$515.5M

disclosed book value

32

positions

11.5%

largest position share

Positions, as of 2026-09-30

top 32 of 32 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1LKFTLAKEFRONT BIOTHERAPEUTICS NV2.0M$59.3M11.5%
2STTKSHATTUCK LABS INC7.6M$52.2M10.1%
3JANXJANUX THERAPEUTICS INC2.9M$50.9M9.9%
4NKTRNEKTAR THERAPEUTICS785,000$47.5M9.2%
5ABVXABIVAX SA376,794$37.3M7.2%
6INSMINSMED INC238,088$27.2M5.3%
7BSXBOSTON SCIENTIFIC CORP550,000$24.0M4.7%
8IRTCIRHYTHM HOLDINGS INC200,980$22.8M4.4%
9ALKSALKERMES PLC550,000$22.3M4.3%
10PRVAPRIVIA HEALTH GROUP INC1.0M$20.7M4%
11MLYSMINERALYS THERAPEUTICS INC800,000$20.1M3.9%
12ZYMEZYMEWORKS INC721,100$19.1M3.7%
13SNDXSYNDAX PHARMACEUTICALS INC812,582$15.3M3%
14KURAKURA ONCOLOGY INC1.3M$13.7M2.6%
15DNLIDENALI THERAPEUTICS INC550,700$11.4M2.2%
16PRAXPRAXIS PRECISION MEDICINES I36,400$10.6M2.1%
17HQYHEALTHEQUITY INC115,796$10.2M2%
18BBIOBRIDGEBIO PHARMA INC150,000$9.9M1.9%
19ALNYALNYLAM PHARMACEUTICALS INC37,000$9.1M1.8%
20HUMHUMANA INC22,000$8.4M1.6%
21ENOVENOVIS CORPORATION267,432$4.9M0.9%
22OKURONKURE THERAPEUTICS INC1.3M$3.6M0.7%
23QTRXQUANTERIX CORP825,000$3.1M0.6%
24GENBGENERATE BIOMEDICINES INC144,756$2.2M0.4%
25ANTXAN2 THERAPEUTICS INC350,877$1.9M0.4%
26PLRXPLIANT THERAPEUTICS INC1.6M$1.7M0.3%
27RCKTROCKET PHARMACEUTICALS INC595,024$1.6M0.3%
28RNTXREIN THERAPEUTICS INC1.7M$1.3M0.3%
29COYACOYA THERAPEUTICS INC229,600$1.2M0.2%
30CRBPCORBUS PHARMACEUTICALS HLDGS168,383$1.1M0.2%
31IMRXIMMUNEERING CORP150,000$614,2500.1%
32ADCTADC THERAPEUTICS SA399,900$487,8780.1%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.